Related Experiment Video
Updated: Mar 13, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer
Nijiro Nohata1, Yusuke Goto2, J Silvio Gutkind1,3
1Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Abstract:
The G-protein-coupled receptor (GPCR) family is the largest family of cell-surface receptors involved in signal transduction. Aberrant expression of GPCRs and G proteins are frequently associated with prevalent human diseases, including cancer. In fact, GPCRs represent the therapeutic targets of more than a quarter of the clinical drugs currently on the market. MiRNAs (miRNAs) are also aberrantly expressed in many human cancers, and they have significant roles in the initiation, development and metastasis of human malignancies. Recent studies have revealed that dysregulation of miRNAs and their target genes expression are associated with cancer progression. The emerging information suggests that miRNAs play an important role in the fine tuning of many signaling pathways, including GPCR signaling. We summarize our current knowledge of the individual functions of miRNAs regulated by GPCRs and GPCR signaling-associated molecules, and miRNAs that regulate the expression and activity of GPCRs, their endogenous ligands and their coupled heterotrimeric G proteins in human cancer.
Insights
G-protein-coupled receptors (GPCRs) and microRNAs (miRNAs) are crucial in cancer. Their dysregulation impacts cancer progression, highlighting their roles in signaling pathways and potential as therapeutic targets.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Oncology
Background:
- G-protein-coupled receptors (GPCRs) are the largest cell-surface receptor family, vital for signal transduction.
- Aberrant GPCR and G protein expression is linked to major human diseases, notably cancer.
- GPCRs are key therapeutic targets, forming the basis for over 25% of marketed drugs.
Purpose of the Study:
- To review the interplay between microRNAs (miRNAs) and GPCR signaling in human cancers.
- To elucidate the roles of miRNAs in regulating GPCRs, their ligands, and associated G proteins.
- To summarize how GPCR-regulated miRNAs influence cancer initiation, development, and metastasis.
Main Methods:
- Literature review of recent studies on miRNA and GPCR interactions in cancer.
- Analysis of miRNA functions regulated by GPCRs and associated molecules.
- Examination of miRNAs targeting GPCRs, ligands, and G proteins.
Main Results:
- MicroRNAs are aberrantly expressed in human cancers, influencing malignancy.
- Dysregulation of miRNA-target gene expression correlates with cancer progression.
- MiRNAs fine-tune various signaling pathways, including GPCR signaling.
Conclusions:
- MiRNAs play significant roles in the initiation, development, and metastasis of human cancers.
- The intricate relationship between miRNAs and GPCR signaling is critical in cancer.
- Understanding these interactions offers potential for novel cancer therapies targeting GPCRs and miRNAs.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

